Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric

Regulatory Peptides

Volumn 150, Issue 1-3, 2008, Pages 88-94

  Estes, A M ^a   Wong, Y Y ^a   Parker, M S ^b   Sallee, F R ^c   Balasubramaniam, A ^c   Parker, S L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; Gi subunit; Receptor dimer; Receptor monomer

Indexed keywords

EDETIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOMER; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CHO CELL; CONTROLLED STUDY; KIDNEY CORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEINS; KIDNEY CORTEX; MALE; PROTEIN BINDING; RABBITS; RECEPTORS, NEUROPEPTIDE Y; SOLUBILITY;

CRICETULUS GRISEUS; ORYCTOLAGUS CUNICULUS;

EID: 45849117292     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.06.002     Document Type: Article

References (79)

1. Fotiadis D., Jastrzebska B., Philippsen A., Muller D.J., Palczewski K., and Engel A. Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. Curr Opin Struct Biol 16 (2006) 252-259
2. Ridge K.D., and Palczewski K. Visual rhodopsin sees the light: structure and mechanism of G protein signaling. J Biol Chem 282 (2007) 9297-9301
3. Ng G.Y., O'Dowd B.F., Lee S.P., Chung H.T., Brann M.R., Seeman P., and George S.R. Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227 (1996) 200-204
4. Baneres J.L., and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329 (2003) 815-829
5. Guo W., Shi L., and Javitch J.A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278 (2003) 4385-4388
6. Klco J.M., Lassere T.B., and Baranski T.J. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J Biol Chem 278 (2003) 35345-35353
7. Fernando H., Chin C., Rosgen J., and Rajarathnam K. Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem 279 (2004) 36175-36178
8. Giguere V., Gallant M.A., de Brum-Fernandes A.J., and Parent J.L. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor. Eur J Pharmacol 494 (2004) 11-22
9. Grant M., Collier B., and Kumar U. Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J Biol Chem 279 (2004) 36179-36183
10. Gregan B., Jurgensen J., Papsdorf G., Furkert J., Schaefer M., Beyermann M., Rosenthal W., and Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279 (2004) 27679-27687
11. Hansen J.L., Theilade J., Haunso S., and Sheikh S.P. Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation. J Biol Chem 279 (2004) 24108-24115
12. Hlavackova V., Goudet C., Kniazeff J., Zikova A., Maurel D., Vol C., Trojanova J., Prezeau L., Pin J.P., and Blahos J. Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J 24 (2005) 499-509
13. Wirz S.A., Davis C.N., Lu X., Zal T., and Bartfai T. Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides 39 (2005) 535-546
14. Herrick-Davis K., Weaver B.A., Grinde E., and Mazurkiewicz J.E. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 281 (2006) 27109-27116
15. Parker S.L., Parker M.S., Sah R., Sallee F.R., and Balasubramaniam A. Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. Regul Pept 139 (2007) 128-135
16. Biddlecome G.H., Berstein G., and Ross E.M. Regulation of phospholipase C-beta1 by Gq and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation. J Biol Chem 271 (1996) 7999-8007
17. Chidiac P., and Ross E.M. Phospholipase C-beta1 directly accelerates GTP hydrolysis by Galphaq and acceleration is inhibited by Gbeta gamma subunits. J Biol Chem 274 (1999) 19639-19643
18. Welsby P.J., Carr I.C., Wilkinson G., and Milligan G. Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit. Br J Pharmacol 137 (2002) 345-352
19. Mixon M.B., Lee E., Coleman D.E., Berghuis A.M., Gilman A.G., and Sprang S.R. Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis. Science 270 (1995) 954-960
20. Philip F., and Scarlata S. Influence of membrane components in the binding of proteins to membrane surfaces. Biochemistry 43 (2004) 11691-11700
21. Howlett A.C. Efficacy in CB1 receptor-mediated signal transduction. Br J Pharmacol 142 (2004) 1209-1218
22. Tesmer V.M., Kawano T., Shankaranarayanan A., Kozasa T., and Tesmer J.J. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 310 (2005) 1686-1690
23. Dinger M.C., Bader J.E., Kobor A.D., Kretzschmar A.K., and Beck-Sickinger A.G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 278 (2003) 10562-10571
24. Parker S.L., Parker M.S., Sallee F.R., and Balasubramaniam A. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept 144 (2007) 72-81
25. Parker S.L., Parker M.S., Sah R., Balasubramaniam A., and Sallee F.R. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur J Pharmacol 579 (2008) 13-25
26. Berglund M.M., Schober D.A., Esterman M.A., and Gehlert D.R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 307 (2003) 1120-1126
27. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 75-76 (1998) 231-238
28. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., Hallberg B., Nordlander M., and Cao Y. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci U S A 100 (2003) 6033-6038
29. Parker S.L., Parker M.S., Sah R., and Sallee F. Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues?. Biochem Biophys Res Commun 335 (2005) 983-992
30. Parker S.L., and Balasubramaniam A. Neuropeptide Y Y2 receptor in health and disease. Br J Pharmacol 153 (2008) 420-431
31. Sheikh S.P., Sheikh M.I., and Schwartz T.W. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am J Physiol 257 (1989) F978-F984
32. Parker S.L., Parker M.S., and Crowley W.R. Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors. Regul Pept 75-76 (1998) 127-143
33. Parker S.L., Parker M.S., Estes M.A., Wong Y.Y., Sah R., Sweatman T., Park E.A.., Balasubramaniam A., and Sallee F.R. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain. J Recept Signal Transduct 28 (2008) 245-263
34. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., and Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270 (1995) 22661-22664
35. Parker S.L., Kane J.K., Parker M.S., Berglund M.M., Lundell I.A., and Li M.D. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist- driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem 268 (2001) 877-886
36. Gicquiaux H., Lecat S., Gaire M., Dieterlen A., Mely Y., Takeda K., Bucher B., and Galzi J.L. Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem 277 (2002) 6645-6655
37. 2+ requirement, and regulation of M current. J Gen Physiol 126 (2005) 243-262
38. Wong R., Fabian L., Forer A., and Brill J.A. Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis. BMC Cell Biol 8 (2007) 15
39. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., and Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 384 (1999) R3-5
40. Parker M.S., Sah R., Sheriff S., Balasubramaniam A., and Parker S.L. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regul Pept 132 (2005) 91-101
41. Parker S.L., Parker M.S., and Crowley W.R. Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport. Regul Pept 82 (1999) 91-102
42. Dunkley P.R., Heath J.W., Harrison S.M., Jarvie P.E., Glenfield P.J., and Rostas J.A. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res 441 (1988) 59-71
43. Desbuquois B., and Aurbach G.D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33 (1971) 732-738
44. Munson P.J., and Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 107 (1980) 220-239
45. Price J.S., Kenny A.J., Huskisson N.S., and Brown M.J. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol 104 (1991) 321-326
46. Sheikh M.I., Kragh-Hansen U., Jorgensen K.E., and Roigaard-Petersen H. An efficient method for the isolation and separation of basolateral-membrane and luminal-membrane vesicles from rabbit kidney cortex. Biochem J 208 (1982) 377-382
47. Parker S.L., Parker M.S., Buschauer A., and Balasubramaniam A. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. Eur J Pharmacol 474 (2003) 31-42
48. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., and Beck-Sickinger A.G. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem 275 (2000) 36043-36048
49. Parker M.S., Crowley W.R., and Parker S.L. Differences in cation sensitivity of ligand binding to Y1 and Y2 subtype of neuropeptide Y receptor of rat brain. Eur J Pharmacol 318 (1996) 193-200
50. Freitag C., Svendsen A.B., Feldthus N., Lossl K., and Sheikh S.P. Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells. J Neurochem 64 (1995) 643-650
51. Dautzenberg F.M., and Neysari S. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors. Pharmacology 75 (2005) 21-29
52. Parker M.S., Lundell I., and Parker S.L. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding. Peptides 23 (2002) 291-302
53. Colecraft H.M., Egamino J.P., Sharma V.K., and Sheu S.S. Signaling mechanisms underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells. J Biol Chem 273 (1998) 32158-32166
54. Parker S.L., Parker M.S., Sweatman T., and Crowley W.R. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. J Pharmacol Exp Ther 286 (1998) 382-391
55. Hilal-Dandan R., Villegas S., Gonzalez A., and Brunton L.L. The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Ther 281 (1997) 267-273
56. Parker M.S., Berglund M.M., Lundell I., and Parker S.L. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation. Peptides 22 (2001) 887-898
57. Grantcharova E., Furkert J., Reusch H.P., Krell H.W., Papsdorf G., Beyermann M., Schulein R., Rosenthal W., and Oksche A. The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process. J Biol Chem 277 (2002) 43933-43941
58. Brighton P.J., Szekeres P.G., Wise A., and Willars G.B. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Mol Pharmacol 66 (2004) 1544-1556
59. Sah R., Balasubramaniam A., Parker M.S., Sallee F., and Parker S.L. Neuropeptide Y as a partial agonist of the Y1 receptor. Eur J Pharmacol 525 (2005) 60-68
60. Zhou Y., Nelson M.E., Kuryatov A., Choi C., Cooper J., and Lindstrom J. Human alpha4beta2 acetylcholine receptors formed from linked subunits. J Neurosci 23 (2003) 9004-9015
61. McLean A.J., and Milligan G. Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. Br J Pharmacol 130 (2000) 1825-1832
62. Davis T.N. Protein localization in proteomics. Curr Opin Chem Biol 8 (2004) 49-53
63. Bohme I., Morl K., Bamming D., Meyer C., and Beck-Sickinger A.G. Tracking of human Y receptors in living cells - a fluorescence approach. Peptides 28 (2007) 226-234
64. El Bahh B., Balosso S., Hamilton T., Herzog H., Beck-Sickinger A.G., Sperk G., Gehlert D.R., Vezzani A., and Colmers W.F. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22 (2005) 1417-1430
65. Kim S.K., and Jacobson K.A. Computational prediction of homodimerization of the A3 adenosine receptor. J Mol Graph Model 25 (2006) 549-561
66. Yu P., Asico L.D., Luo Y., Andrews P., Eisner G.M., Hopfer U., Felder R.A., and Jose P.A. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 70 (2006) 1072-1079
67. Morello J.P., Salahpour A., Petaja-Repo U.E., Laperriere A., Lonergan M., Arthus M.F., Nabi I.R., Bichet D.G., and Bouvier M. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry 40 (2001) 6766-6775
68. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255 (1980) 7108-7117
69. Abramson S.N., McGonigle P., and Molinoff P.B. Evaluation of models for analysis of radioligand binding data. Mol Pharmacol 31 (1987) 103-111
70. Broadley K.J., Nederkoorn P.H., Timmerman H., Timms D., and Davies R.H. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors. J Theor Biol 205 (2000) 297-320
71. Zhou J., Sims C., Chang C.H., Berti-Mattera L., Hopfer U., and Douglas J. Proximal tubular epithelial cells possess a novel 42-kiloDalton guanine nucleotide-binding regulatory protein. Proc Natl Acad Sci U S A 87 (1990) 7532-7535
72. Labelle M., Boulanger Y., Fournier A., St Pierre S., and Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides 18 (1997) 801-808
73. Jin Z., Yanagisawa H., and Wada O. Characterization of G-proteins in rat glomeruli. Nippon Jinzo Gakkai Shi 34 (1992) 349-352
74. Hansen P.B., Castrop H., Briggs J., and Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14 (2003) 2457-2465
75. Gravotta D., Deora A., Perret E., Oyanadel C., Soza A., Schreiner R., Gonzalez A., and Rodriguez-Boulan E. AP1B sorts basolateral proteins in recycling and biosynthetic routes of MDCK cells. Proc Natl Acad Sci U S A 104 (2007) 1564-1569
76. Morris D.P., Lei B., Wu Y.X., Michelotti G.A., and Schwinn D.A. The alpha 1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin coated pits. J Biol Chem (2007)
77. Lee E.W., Michalkiewicz M., Kitlinska J., Kalezic I., Switalska H., Yoo P., Sangkharat A., Ji H., Li L., Michalkiewicz T., Ljubisavljevic M., Johansson H., Grant D.S., and Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111 (2003) 1853-1862
78. Callanan E.Y., Lee E.W., Tilan J.U., Winaver J., Haramati A., Mulroney S.E., and Zukowska Z. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Am J Physiol Renal Physiol 293 (2007) F1811-F1817
79. Parker S.L., Parker M.S., Wong Y.Y., Sah R., Balasubramaniam A., and Sallee F.R. Mutation of N-terminal residues in the Y2 neuropeptide Y (NPY) receptor reduces adherence and accelerates internalization of the CHO cell expression. 2007 Meeting of the Neuroscience Society (2007) Abstract #195.9/XX6